Pfizer Stock Is Soaring Because Its Covid Antiviral Appears to Work Really, Really Well

2 years ago 249

This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn http://www.djreprints.com.

https://www.barrons.com/articles/pfizer-stock-covid-antiviral-51636111795


Updated Nov. 5, 2021 9:19 americium ET / Original Nov. 5, 2021 7:30 americium ET

  • Order Reprints
  • Print Article

Pfizer banal changeable higher aft beardown results for its Covid-19 antiviral.

Jonas Roosens/BELGA/AFP via Getty Images

Pfizer banal soared aft the institution said its Covid-19 pill chopped the hazard of hospitalization oregon decease by 89% successful a proceedings of high-risk non-hospitalized adults, besting by a important borderline the efficacy of Merck‘s highly-touted Covid-19 pill molnupiravir.

Shares of Pfizer (ticker: PFE) jumped 12.2% successful premarket trading Friday, portion Merck (MRK) shares dropped 8.6%.

The...


Read Entire Article